Bladder health
Natural health product licensed in Canada
- Licence holder
- Les Emballages Façoteck
- NPN or DIN-HM
- 80130360
- Status
- Active licence
- Licence date
- 2 April 2024
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vaccinium macrocarpon Source : Vaccinium macrocarpon - Graine | 250 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Hypromellose, farine de riz
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Femmes | minimum: 18 years | 2 Capsule | 1 Tous les jours |
| Hommes | minimum: 18 years | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Men 18 years and older: Helps to improve International Prostate Symptom Scores. Men 18 years and older: Helps reduce urinary symptoms in men over 45 years old with benign prostatic hyperplasia (BPH). Men 18 years and older: Helps to support normal urinary function. Men 18 years and older: Helps to improve lower urinary tract symptoms (LUTS) in men. Men 18 years and older: Helps maintain normal urinary voiding and storage functions in men over 45 years old with lower urinary tract symptoms (LUTS). Men 18 years and older: Helps relieve the urologic symptoms (e.g. weak urine flow, incomplete voiding, frequent daytime and night-time urination) associated with benign prostatic hyperplasia (BPH). Women 18 years and older: Helps reduce overactive bladder in women. Women 18 years and older: Helps reduce daily number of micturitions in women. Women 18 years and older: Helps improve urinary symptoms in women. Women 18 years and older: Helps reduce daily number of urgency episodes in women. Women 18 years and older: Helps reduce urgency episodes in women. Women 18 years and older: Helps reduce urinary frequency in women. Women 18 years and older: Helps improve perceived bladder condition in women.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80130360
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.